Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00518973 · ClinicalTrials.gov registry record · NA
Trial of Quetiapine in Anorexia Nervosa
A NA study, sponsored by University of California, San Diego.
- Completed
- Registry status
- NA
- Development phase
- 21
- Enrollment target
NCT00518973 is a NA study that has completed, run by University of California, San Diego. The registered enrollment target is 21 participants.
The verdict
NCT00518973, a NA study, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
Study Summary
This research study is being held at UCSD to determine whether the medication Quetiapine helps people suffering from anorexia nervosa by reducing core eating disorders symptoms. This study will see if the medication Quetiapine helps symptoms of anxiety, depression, and obsessionality, in addition to increasing BMI. Men and women between the ages of 18-65 and are currently suffering from anorexia nervosa are needed.
Interventions
- DRUG Placebo
- DRUG Quetiapine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2006-07 |
| Est. Completion | 2010-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00518973
The ClinicalTrials.gov registry entry for NCT00518973 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00518973 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00518973 about?
NCT00518973 is a clinical study titled "Trial of Quetiapine in Anorexia Nervosa". This research study is being held at UCSD to determine whether the medication Quetiapine helps people suffering from anorexia nervosa by reducing core eating disorders symptoms. This study will see if the medication Quetiapine helps symptoms of anxiety, depression, and obsessionality, in addition to...
What is the current status of trial NCT00518973?
This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2006-07. Estimated completion is 2010-05.
What interventions are being tested in trial NCT00518973?
The interventions under investigation include: Placebo (DRUG), Quetiapine (DRUG).
Who is sponsoring clinical trial NCT00518973?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.